Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2022 Nov. 16 [cited 2025 Apr. 18];6(6):s46. Available from: https://skin.dermsquared.com/skin/article/view/1801